Clinical Trial Contact Request

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

First Name*

Last Name*

Email Address*

Confirm Email Address*

Phone Number*

Zip Code / City*

Best time to call

Any Time

Morning

Afternoon

(1024)

By submitting this form, you accept our Terms & Conditions and grant permission for us to contact you. We will not sell or share your information (Privacy Policy). Please do not submit another person’s name or email without his or her consent.

Clinical Trial Contact Request

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

Find Care

Find Care

Patient Resources

Patient Resources

Treatment Options

Treatment Options

Discover UCLA Health

Discover UCLA Health

Get the UCLA Health App

Get the UCLA Health App